Search

Search Results

• GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients

  Lidia Wydeheft , Justyna Jusiak , Paulina Halik, Paulina Malon, Kornelia Kędziora-Kornatowska

  67673

  2026-01-10
• Neuroprotective Mechanisms of GLP‑1 Pathway Activation in Parkinson’s Disease - Foundations For Future Disease‑Modifying Strategies

  Gabriela Chmiel, Patryk Bachurski, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Paweł Wiśniewski, Paweł Witkowski, Bartosz Zarański

  68253

  2026-02-01
• The Impact of GLP-1 Receptor Agonists on Body Composition and Musculoskeletal Integrity: A Review of Mechanisms, Protective Strategies, and Clinical Perspectives

  Szymon Domagała, Zuzanna Wiater, Aleksandra Włodarczyk, Karolina Brankowska, Marta Jakubowska, Michał Olejnik, Paulina Tymińska, Piotr Artur Górka, Julia Frączek, Witold Kądziołka

  69771

  2026-03-24
• Drugs Used in the Treatment of Obesity – A Systematic Review

  Olga Plinta, Filip Bednarek, Alicja Hojda, Izabela Małajewicz, Natalia Nawrocka, Karolina Oskroba, Małgorzata Pietrzyk, Hanna Rodak, Dawid Stępień

  67976

  2026-02-05
• Tirzepatide - role in obesity, health and physical wellness. Information overview

  Anna Hanslik, Magdalena Mendak, Agata Białek, Agnieszka Walczak, Adrian Hovagimyan, Monika Olszanecka, Tomasz Olszanecki

  58191

  2025-02-13
• Tirzepatide - a new drug with great potential in controlling glycemia and body weight

  Magdalena Stabrawa , Filip Prusinowski , Maria Teresa Sarata , Aleksandra Kutaj, Tatyana Savitskaya, Ignacy Hatala, Kiryl Savitski

  69364

  2026-03-06